HR

Hareesha Rajani Gunisetty

Active Director Director DIN 09468038
DIN 09468038 First appointment Jan 2022 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Hareesha Rajani Gunisetty

Data last updated:

Hareesha Rajani Gunisetty is a Director at Khs Pharmaceuticals Private Limited (since 2022). The company operates in Trading.

DIN 09468038
Primary Designation Director
Industry Trading
First Appointment 14 Jan 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Khs Pharmaceuticals Private Limited U51909TG2022PTC158784
Director14 Jan 20222022Active

Board colleagues of Hareesha Rajani Gunisetty

Directorship timeline

Open interactive timeline →
Khs Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Hareesha Rajani Gunisetty

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hareesha Rajani Gunisetty

Hareesha Rajani Gunisetty currently holds 1 directorship: Khs Pharmaceuticals Private Limited (Director, since 14 Jan 2022).

Hareesha Rajani Gunisetty was first appointed on 14 Jan 2022 as Director at Khs Pharmaceuticals Private Limited.

The current boards of Hareesha Rajani Gunisetty's companies include Haseena Shaik (Khs Pharmaceuticals Private Limited), Saritha Konudula (Khs Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available